US Issues Recall of Shrimp Due to Radioactivity Concerns

U.S. health authorities have recalled shrimp imported from Indonesia due to potential contamination with radioactive cesium-137, emphasizing food safety concerns and the importance of monitoring imported seafood.
In an important public health update, U.S. authorities have announced the recall of certain frozen shrimp products over concerns related to potential radioactivity contamination. The recall implicates shrimp imported from Indonesia, specifically from a company named PT. Bahari Makmur Sejati. These products have been distributed across 13 states through retail giant Walmart.
The issue came to light after the detection of the radioactive isotope cesium-137 in some of the imported shrimp. While the levels of radioactivity found were minimal and posed no immediate health hazard, the Food and Drug Administration (FDA) emphasized the importance of caution. The agency clarified that none of the shrimp currently available in U.S. stores tested positive for radioactivity; however, the concern lies with the condition in which the shrimp was processed, packed, or stored.
Officials indicated that the shrimp may have been subjected to insanitary conditions that led to contamination, raising longer-term safety questions. Chronic exposure to low doses of cesium-137 has been associated with an increased risk of developing cancer over time.
In response, the FDA has urged Walmart to stage a recall and advised consumers who purchased the affected shrimp to dispose of it properly. Although the contamination levels are low, the recall underlines the importance of food safety monitoring in imported seafood.
This recall highlights the need for rigorous safety checks in the seafood supply chain and serves as a reminder for consumers to remain vigilant about the origins of their seafood products. For more details, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Differences in Treatment Preferences for Obesity and Sleep Apnea Among Patients and Healthcare Providers
A study reveals contrasting treatment preferences between patients and healthcare providers for obesity-related sleep apnea, highlighting the importance of shared decision-making in effective care strategies.
Nearly Half of Drug-Related Deaths Among Healthcare Workers Involved Hospital-Only Medications
A new study uncovers that 43% of drug-related deaths among healthcare professionals involve medications obtained from their workplaces, highlighting the urgent need for mental health support and drug safety measures.
Research Reveals That Infants Can Detect Pain Before Fully Understanding It
New research from UCL uncovers how infants develop the ability to sense pain before fully understanding it, emphasizing tailored neonatal care and pain management strategies.
FDA Implements Daily Updates on Adverse Event Data for Enhanced Transparency
The FDA now publishes adverse event data daily, improving transparency and enabling quicker responses to safety concerns related to medications and biologics.



